Expense games

Revenue games inflate the top line; expense games work at the other end of the P&L, and they are quieter for it. The move is simple to state and hard to see: take a cost that belongs in this year's profit and keep it out, so the margin comes in higher than the business actually earned. The cost is never destroyed — cash still left the company, or a liability still built up — it is only parked: pushed onto the balance sheet as an asset, left un-provided, shifted to a related party or a later period, or relabelled as a one-off so the profit management highlights excludes it. Every expense game is a variation on that one sentence, and the forensic reader's job is to find where the cost was parked. illustrative

This is harder to catch than a revenue game because a real cost and a parked cost look identical on the face of the P&L — both simply show a lower expense line and a fatter margin. You cannot tell them apart from the income statement alone. You tell them apart by reconciliation, the stance installed two modules ago: a margin that rises for an honest reason — real operating leverage, a genuine mix shift — turns into cash, while a margin that rises because a cost was parked does not. The cash still went out, so operating cash falls behind profit, and the parked cost shows up as something swelling on the balance sheet. The signature of an expense game is therefore a pair of movements, never a single number: profit up, cash conversion down, and some asset — capital work in progress, intangibles, a stretched payable, an unmoved provision — carrying the cost the P&L refused. So the question is: when a margin improves too smoothly, where did the missing cost go, and does the reconciliation rule out that it was simply moved?

The mechanism rests on accrual accounting and the matching principle — a cost should be recognised in the period whose revenue it helped earn. Every expense game is a violation of matching in the company's favour: a charge that should hit this year is deferred or hidden, so this year's profit borrows from a future one. There are four levers, worth learning as a set because they leave one shared signature.

Capitalise what should be expensed. The most powerful lever, because it converts an expense directly into an asset. Development cost, software, a slice of project staff salaries, even interest — instead of hitting the P&L, they go onto the balance sheet as capital work in progress or an intangible, and are released slowly through amortisation. Done honestly, against a real asset under construction or a genuine development project, this is exactly what the standards require. Done aggressively, it parks ordinary running costs — routine R&D that should be expensed, salaries of staff doing normal work — as assets, so margin jumps and the cost is smeared into years the reader will not connect back. The tell is CWIP and intangibles rising faster than sales, and a CWIP balance that never converts into a producing, depreciating asset.

Under-provide for what will go wrong. A provision is a charge booked today for a probable but uncrystallised cost — doubtful debts, warranties, inventory that will be written down, a legal claim. Because the amount is a judgement, it is the easiest expense to shrink: set the doubtful-debt percentage a little low, assume warranty claims rarer than history says, delay the write-down a quarter, and this year's expense falls. Nothing was booked, so nothing shows in cash; the cost waits as an unrecognised liability. The reconciliation is to tie the provision to the thing it covers — the ageing of receivables, the warranty history, the age of the inventory — and ask whether the risk really shrank or was just left unrecorded. An under-provision is profit borrowed from a future write-off.

Shift or defer the cost. Some costs move sideways rather than up. A charge due this year is negotiated into next year, or routed through a related party — a promoter-owned entity absorbs an expense, or sells to the company at a soft price — so the listed company's costs look lower than an arm's-length business would bear. This is the hardest lever to see from the numbers, because there may be no swelling asset: the cost genuinely left this P&L. The related-party note and the segment detail matter more here than the ratios, and the tie is to sustainability — a cost base propped up by a related party is not the company's own, and can be withdrawn the moment the promoter's incentive changes.

Call a recurring cost a one-off. The last lever concedes the cost but changes its label. A genuine one-time charge is properly shown as an exceptional item below the line, and analysts rightly strip it out to see underlying earnings. The game is to book a cost that in fact recurs every year as "exceptional" each time, so the "adjusted" profit management highlights permanently excludes a permanent cost. The tell is history: a one-off that appears in four years running is an operating cost in a costume, and the defence is to add it back and judge the business on the profit that includes it.

Four mechanisms, one convergence — and it is the pattern, not any single lever, that you learn to see. Whenever a margin improves, ask the reconciliation: did operating cash improve with it, or did operating cash fall behind while CWIP, intangibles, payables or an unmoved provision quietly grew? A margin gain corroborated by cash is real; a margin gain shadowed by a swelling parking-spot is a cost that was moved, and the balance sheet is telling you where.

Expense games cannot be caught with a rule because the very same entry — capitalising a cost as an asset — is mandatory in one business and a warning sign in another. The instruction "reconcile the capitalised cost to a real asset" is constant; whether it passes flips with the sector, and this inversion is the module's core.

Capitalising a cost is not itself honest or dishonest — it is honest exactly when a real asset is being created and dishonest when one is not, and the same journal entry sits on both sides of that line. For the pharma developer, the software builder, the road and the property project, an asset is genuinely taking shape, and expensing the cost that builds it would understate both the asset and early-year profit. For the mature FMCG company there is no asset being built; its costs are the recurring costs of running a brand, and capitalising them is simply opex moved off the P&L. A reader who learns "capitalisation is fine" from a software firm will bless an FMCG firm's capitalised advertising; one who learns "capitalisation is a red flag" from that FMCG firm will wrongly penalise a genuine developer for following the standard. Neither verdict travels. What travels is the question — is there a real asset here, and does the capitalised cost convert into it and then amortise? Carry that, not a verdict.

Take a composite mid-cap industrial that has quietly re-rated on improving profitability. Operating margin has climbed about 600 basis points over two years, the commentary credits "operating leverage and cost discipline," and on the face of the P&L it is a clean improvement. The forensic reader does not admire the margin; he asks where the cost went. illustrative

Margin against cash first. Reported profit rose from ₹300 crore to ₹460 crore, but operating cash barely moved — cash conversion fell from about 0.9 to 0.4 — so the extra profit did not become money. That is the gap, and it has a location. Read the balance sheet for the parking-spot: CWIP and intangibles together roughly tripled, from ₹180 crore to ₹560 crore, and now sit at a fifth of the balance sheet, the notes showing a rising line of "product development" and "technical know-how" capitalised each year. Then the provision line: the doubtful-debt charge fell even as receivables aged, and a "business reorganisation" exceptional appeared below the line — the third such "one-off" in three years. illustrative

No single one of these is proof. A genuine capital programme, a real development asset, a truly final restructuring — each could innocently explain one line. But three moving the same way at once is a coherent pattern, not three coincidences: the margin improved not because the business earned more per rupee of cost, but because costs were moved — some capitalised, some left un-provided, some pushed below the line. The "operating leverage" story is contradicted by the cash it never produced, and that is now the thing the company must explain. Build the habit of running this before you accept a margin story: set margin beside cash conversion over two or three years; if margin rose while conversion fell, go straight to CWIP, intangibles and the provision lines and ask what grew to absorb the missing cost. Where the gain is matched by cash, believe it; where it is matched instead by a swelling asset or an un-booked charge, you have found the cost the P&L refused.

When margin jumps without turning into cash while intangibles and CWIP balloon, the forensic analyst does not attack the margin directly — he asks the capitalisation into the open: "Margin is up around 600 basis points but operating cash conversion fell to about 0.4 while capitalised development and CWIP tripled — how much of this year's cost improvement is spend that was capitalised rather than expensed, what exactly is in that intangible, and when does it start amortising?" The question names the parked cost and asks the company to show it is a real asset.

A good answer decomposes:

"Fair to ask. About ₹120 crore of the balance-sheet build is a new line being commissioned this quarter — genuine CWIP that moves to plant and starts depreciating from Q3. The capitalised development is roughly ₹90 crore, all on two products past technical feasibility that are already shipping; we amortise over five years and amortisation has already started — you'll see it in the segment note. We capitalise nothing on the research phase; that's expensed as incurred. Cash conversion is low this year because of the CWIP outflow and a working-capital build we'd expect to reverse. Strip the commissioning and conversion is closer to 0.8." illustrative

It accepts the gap, breaks the capitalised balance into named, checkable pieces, states the policy line between expensed research and capitalised development, points to amortisation already running, and gives a number you can hold it to next quarter. An evasive answer reassures without reconciling:

"We follow all applicable accounting standards and our policies are fully compliant and audited. Capitalisation is a normal part of how a business like ours invests for the future, and we're very comfortable with the quality of our balance sheet. Cash flows are lumpy quarter to quarter; we manage for the full year. The margin improvement reflects the operating leverage and cost discipline we've been building, and we're confident it's sustainable."

"Compliant and audited" and "investing for the future" are assertions, not the decomposition asked for; it names no product, no amortisation, no research/development split, and reaches for "standards" precisely where the numbers should have been. The follow-up that settles it — "Of the capitalised intangible, how much is amortising today, and what was expensed to research versus capitalised to development this year and last?" — forces the split and the amortisation into the open, where a development asset that never starts running down cannot hide behind "we invest for the future." A company whose intangible is a real, amortising asset volunteers the amortisation; the silence is the tell.

The reconciliation locates a parked cost; it does not, by itself, prove the parking illegitimate. Capitalised development that swells the balance sheet is consistent with an aggressive management flattering profit and with a real, valuable asset built by a genuine innovator — and the signature on the face of the accounts is the same in both. A rising CWIP balance can be a plant that will soon produce or a cost warehouse that never will. The stance tells you a cost was moved and where; whether the asset is real comes from the note on what was capitalised, whether it amortises, whether the CWIP converts, and from whether an asset should exist here at all. Nor does a low expense line mean dishonesty — some firms genuinely have low provisions because receivables are pristine and products rarely fail. Reserve suspicion for the low cost that comes with the pair, not for a low cost on its own. And the cleanest cost-shift — an expense absorbed by a related party — may leave no swelling asset to find: reconciliation to the balance sheet will not catch it, only the related-party note, the segment detail and margins too good for the industry will. That is exactly why Part Four goes on to the auditor, the related-party web and the promoter's incentives.

Three ways readers get fooled follow directly. The first is admiring a margin without pricing the cost behind it — attributing a rising margin to "leverage" or "discipline" without ever setting it beside cash conversion and the balance-sheet accounts a moved cost would swell. The defence is unglamorous: never let a margin improvement stand without checking that cash improved with it. The second is treating capitalisation as always fine or always sinister — waving through an FMCG firm's capitalised advertising because a software firm's capitalised development was normal, or penalising a genuine pharma developer because a fraud once hid costs that way. Both carry a verdict across a sector boundary it does not survive; only the question travels. The third is anchoring on the profit management hands you — the "adjusted" number is fair most of the time, but the recurring "one-off" makes it structurally too high, and it is the number the headlines and the model all fix on. Keep your own count: pull three or four years of exceptional items together, and any charge that recurs goes back into operating cost, whatever the label. The company decides what it calls a cost; you decide what you treat as one.